Docoh
Loading...

CGTX Cognition Therapeutics

Company profile

CGTX stock data

(
)

Investment data

Data from SEC filings
Securities sold
Number of investors

Calendar

22 Oct 21
31 Dec 21
Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
13 Oct 21 Lisa Ricciardi Common Stock Buy Acquire P No No 12 12,500 150K 12,500
13 Oct 21 James Michael O'Brien Common Stock Buy Acquire P No No 12 5,000 60K 5,000
13 Oct 21 Mark H. Breedlove Common Stock Sell Dispose S Yes No 12 11.74 140.88 404,439
13 Oct 21 Mark H. Breedlove Common Stock Conversion Acquire C Yes No 0 4,354 0 404,451
13 Oct 21 Mark H. Breedlove Common Stock Conversion Acquire C Yes No 0 93,296 0 400,097
13 Oct 21 Mark H. Breedlove Common Stock Conversion Acquire C Yes No 0 225,281 0 306,801
13 Oct 21 Mark H. Breedlove Common Stock Conversion Acquire C Yes No 0 36,714 0 81,520
13 Oct 21 Mark H. Breedlove Common Stock Conversion Acquire C Yes No 0 44,806 0 44,806
13 Oct 21 Mark H. Breedlove Warrant Common Stock Dispose X Yes No 0 4,354 0 0
13 Oct 21 Mark H. Breedlove Series B-1 Convertible Preferred Stock Common Stock Conversion Dispose C Yes No 0 301,978 0 0

Financial report summary

?
Competition
Cassava Sciences

Financial reports

No filings

Proxies

No filings